Department of Chemistry, College of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, PR China.
Bioorg Med Chem Lett. 2012 Jul 1;22(13):4471-4. doi: 10.1016/j.bmcl.2012.03.023. Epub 2012 Mar 11.
A series of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and some novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles bearing 3,4,5-trimethoxyphenyl moiety were synthesized and screened for their anticancer activity. The preliminary bioassay results indicated that compounds 14 and 16 showed much stronger cytotoxicity than Doxorubicin against HepG2 cell lines with IC(50) values of 0.58 and 3.17 μM, respectively. Meanwhile compound 16 also exhibited a broad spectrum of antitumor activity against MCF-7 and MKN45 with IC(50) values of 10.92 and 13.79 μM, respectively.
一系列 3,4-二取代-5-(3,4,5-三甲氧基苯基)-4H-1,2,4-三唑和一些新型含 3,4,5-三甲氧基苯基部分的 5,6-二氢-[1,2,4]三唑并[3,4-b][1,3,4]噻二唑被合成并筛选其抗癌活性。初步的生物测定结果表明,化合物 14 和 16 对 HepG2 细胞系的细胞毒性比阿霉素强得多,IC50 值分别为 0.58 和 3.17 μM。同时,化合物 16 对 MCF-7 和 MKN45 也表现出广谱的抗肿瘤活性,IC50 值分别为 10.92 和 13.79 μM。